Cargando…

Overcoming TKI resistance in fusion-driven NSCLC: new generation inhibitors and rationale for combination strategies

During the last several years, multiple gene rearrangements with oncogenic potential have been described in NSCLC, identifying specific clinic-pathological subgroups of patients that benefit from a targeted therapeutic approach, including anaplastic lymphoma kinase (ALK), c-ros protooncogene 1 (ROS1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russo, Alessandro, Cardona, Andrés F., Caglevic, Christian, Manca, Paolo, Ruiz-Patiño, Alejandro, Arrieta, Oscar, Rolfo, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Review Article on Looking for Chimeras in NSCLC: Widen Therapeutic Options Targeting Oncogenic Fusions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815353/ https://www.ncbi.nlm.nih.gov/pubmed/33489820 http://dx.doi.org/10.21037/tlcr-2019-cnsclc-06

Ejemplares similares

Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going?
por: Passiglia, Francesco, et al.
Publicado: (2020)

How to select the best upfront therapy for metastatic disease? Focus on ALK-rearranged non-small cell lung cancer (NSCLC)
por: Xia, Bing, et al.
Publicado: (2020)

Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy
por: Suda, Kenichi, et al.
Publicado: (2020)

Future perspectives from lung cancer pre-clinical models: new treatments are coming?
por: Bersani, Francesca, et al.
Publicado: (2020)

Central nervous system metastases and oligoprogression during treatment with tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer: how to treat and when?
por: Schoenmaekers, Janna Josephus Anna Oda, et al.
Publicado: (2020)

Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?—a literature review
por: Leone, Gianmarco, et al.
Publicado: (2020)

The role of plasma genotyping in ALK- and ROS1-rearranged lung cancer
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2020)

Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won
por: Tabbò, Fabrizio, et al.
Publicado: (2020)

Decade in review: a new era for RET-rearranged lung cancers
por: Choudhury, Noura J., et al.
Publicado: (2020)

Narrative review of molecular pathways of kinase fusions and diagnostic approaches for their detection in non-small cell lung carcinomas
por: Matter, Matthias S., et al.
Publicado: (2020)

How selecting best therapy for metastatic NTRK fusion-positive non-small cell lung cancer?
por: Ekman, Simon
Publicado: (2020)

Integrating immune checkpoint inhibitors and targeted therapies in the treatment of early stage non-small cell lung cancer: a narrative review
por: Ortega-Franco, Ana, et al.
Publicado: (2020)

How selecting best upfront therapy for metastatic disease?—Focus on ROS1-rearranged disease
por: Landi, Lorenza, et al.
Publicado: (2020)

Complications with axial presacral lumbar interbody fusion: A 5-year postmarketing surveillance experience
por: Gundanna, Mukund I., et al.
Publicado: (2011)

Cost comparison of patients with 3-level artificial total lumbar disc replacements versus 360° fusion at 3 contiguous lumbar vertebral levels: an analysis of compassionate use at 1 site of the US investigational device exemption clinical trial
por: Buttacavoli, Frank A., et al.
Publicado: (2010)

Anterior Cervical Corpectomy and Fusion Accelerates Degenerative Disease at Adjacent Vertebral Segments
por: Pickett, Gwynedd E., et al.
Publicado: (2008)

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19
por: Cui, W., et al.
Publicado: (2021)

182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study
por: Marin, E., et al.
Publicado: (2021)

miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase Cδ
por: Gentilin, Erica, et al.
Publicado: (2013)

179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center
por: Pierre, C., et al.
Publicado: (2021)

Eye health in the future: what are the challenges for the next twenty years?
por: Taylor, Hugh R
Publicado: (2008)

Overlap of Autism and Seizures: Understanding Cognitive Comorbidity
por: Khetrapal, Neha
Publicado: (2010)

The ICMJE and URM: Providing Independent Advice for the Conduct of Biomedical Research and Publication
por: Van der Weyden, Martin B
Publicado: (2007)

A Look at CMAJ: A Misty Image Indeed
Publicado: (2006)

Are Jews Smarter Than Everyone Else?
por: Gilman, Sander L.
Publicado: (2008)

My Close Friends Lurk All Around The House, And He Knows Not!
por: Singh, Shakuntala A.
Publicado: (2009)

From Here and Now to Infinity and Eternity: A Message to New Medical Doctors(*)
por: Lapeña, José Florencio F.
Publicado: (2014)

A Ballad for the Bald!
por: Srinivas, B
Publicado: (2015)

The Allan Burns mummies: A history and future prospect of an anatomical collection
por: Lee, J, et al.
Publicado: (2017)

Black Looks....at Risks
por: Black, Douglas
Publicado: (1991)

Black Looks... at Literacy
por: Black, Douglas
Publicado: (1991)

Black Looks... at 'Population Medicine'
por: Black, Douglas
Publicado: (1991)

Black Looks... at Inducements
por: Black, Douglas
Publicado: (1991)

Black Looks... at Paternalism
por: Black, Douglas
Publicado: (1993)

Black Looks... at Audit
por: Black, Douglas
Publicado: (1993)

Black Looks... at Habits
por: Black, Douglas
Publicado: (1993)

Black Looks... Back... and Ahead
por: Black, Douglas
Publicado: (1993)

Black Looks ... at 'Isms'
por: Black, Douglas
Publicado: (1992)

Black Looks ... at Prevention and Cure
por: Black, Douglas
Publicado: (1992)

Black Looks ... at Elections
por: Black, Douglas
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_ib7egiekj40kqc622btpthjk6i